使用 gabapentinoid 治疗和自我伤害的风险:基于人口的自我控制病例系列研究研究
Andrew S C Yuen1,2, Boqing Chen1,2, Adrienne Y L Chan3,4
1Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
概括
gabapentinoid 治疗与自我伤害风险有关,特别是在治疗前和治疗后. 在整个 gabapentinoid 治疗过程中,密切监测患者至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 临床流行病学临床流行病学
- 公共卫生 公共卫生
背景情况:
- gabapentinoids 是一个常见的处方药.
- 自伤是严重的公共卫生问题.
研究的目的:
- 为了估计 gabapentinoid 治疗对自我伤害的影响.
- 调查 gabapentinoid 使用和自我伤害事件之间的时间关系.
主要方法:
- 基于人口的自我控制案例系列研究.
- 利用了英国临床实践研究数据链 Aurum,医院情节统计和国家统计局数据库.
- 包括在2000年至2020年期间有10002名成年人服用 gabapentinoid 处方和发生自伤事件.
主要成果:
- 在 gabapentinoid 治疗前 90 天观察到自我伤害的风险增加 (aIRR 1.69).
- 自伤风险在治疗期间下降 (aIRR 1.06),但在停止治疗后的14天内显著增加 (aIRR 3.02).
- 结果在各个子组和敏感性分析中是一致的.
结论:
- gabapentinoids 与自我伤害风险之间的关联是复杂的,在治疗前后都有高风险的时期.
- 研究结果不支持 gabapentinoid 治疗对自我伤害的直接因果关系.
- 强调需要在整个 gabapentinoid 治疗过程中对患者进行警的自我伤害监测.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Drug Toxicity: Risk factors
248
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248


